ECSP066808A - Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa - Google Patents

Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa

Info

Publication number
ECSP066808A
ECSP066808A EC2006006808A ECSP066808A ECSP066808A EC SP066808 A ECSP066808 A EC SP066808A EC 2006006808 A EC2006006808 A EC 2006006808A EC SP066808 A ECSP066808 A EC SP066808A EC SP066808 A ECSP066808 A EC SP066808A
Authority
EC
Ecuador
Prior art keywords
hydroxypropylmethylcellulose
sodium carboxymethylcellulose
ophthalmic solution
hydrogen peroxide
preservative
Prior art date
Application number
EC2006006808A
Other languages
English (en)
Inventor
Fu-Pao Tsao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP066808A publication Critical patent/ECSP066808A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Se proporcionan una solución oftálmica comprende una fuente de peróxido de hidrógeno en una cantidad suficiente para resultar entre aproximadamente 0.001% y aproximadamente 0.01% en peso de peróxido de hidrógeno estabilizado en dicha formulación como un conservador, uno o más estabilizadores de peróxido de hidrógeno ocularmente compatibles, hidroxipropilmetilcelulosa y carboximetilcelulosa de sodio, así como también composiciones farmacéuticas que comprenden tales soluciones
EC2006006808A 2004-03-17 2006-08-30 Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa ECSP066808A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55388004P 2004-03-17 2004-03-17

Publications (1)

Publication Number Publication Date
ECSP066808A true ECSP066808A (es) 2006-11-16

Family

ID=34962605

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006808A ECSP066808A (es) 2004-03-17 2006-08-30 Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa

Country Status (15)

Country Link
US (4) US20050244509A1 (es)
EP (1) EP1732511A1 (es)
JP (1) JP2007529458A (es)
KR (1) KR20070005625A (es)
CN (1) CN1933812A (es)
AU (1) AU2005224012B2 (es)
BR (1) BRPI0508858A (es)
CA (1) CA2557795A1 (es)
EC (1) ECSP066808A (es)
IL (1) IL177725A0 (es)
MA (1) MA28507B1 (es)
NO (1) NO20064661L (es)
RU (1) RU2006136092A (es)
TN (1) TNSN06293A1 (es)
WO (1) WO2005089715A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
KR20150017002A (ko) * 2006-03-17 2015-02-13 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 눈용 조성물
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
TWI419719B (zh) * 2007-08-31 2013-12-21 Novartis Ag 隱形眼鏡產物
AU2013224663B2 (en) * 2007-08-31 2015-01-15 Alcon Inc. Contact Lens Products
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
TW201127423A (en) 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
US20150000936A1 (en) * 2011-12-13 2015-01-01 Schlumberger Technology Corporation Energization of an element with a thermally expandable material
MY196736A (en) 2015-12-03 2023-05-03 Alcon Inc Contact lens packaging solutions
US10561593B2 (en) * 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
CN107041892B (zh) * 2016-07-12 2021-02-26 合肥九研医药科技开发有限公司 羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880601A (en) * 1985-09-27 1989-11-14 Laboratoires, P.O.S. Hydrogen peroxide disinfecting system for contact lenses
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
TWI236377B (en) * 2000-09-28 2005-07-21 Novartis Ag Stabilized hydrogen peroxide solutions
PE20030729A1 (es) * 2002-01-18 2003-10-21 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas

Also Published As

Publication number Publication date
AU2005224012B2 (en) 2009-07-02
WO2005089715A1 (en) 2005-09-29
KR20070005625A (ko) 2007-01-10
AU2005224012A1 (en) 2005-09-29
RU2006136092A (ru) 2008-04-27
CN1933812A (zh) 2007-03-21
US20120220961A1 (en) 2012-08-30
CA2557795A1 (en) 2005-09-29
BRPI0508858A (pt) 2007-08-28
EP1732511A1 (en) 2006-12-20
US20080096978A1 (en) 2008-04-24
NO20064661L (no) 2006-12-14
US20100143493A1 (en) 2010-06-10
US20050244509A1 (en) 2005-11-03
TNSN06293A1 (en) 2007-12-03
JP2007529458A (ja) 2007-10-25
MA28507B1 (fr) 2007-04-03
IL177725A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
ECSP066808A (es) Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
PE20131324A1 (es) Formulacion subcutanea de anticuerpo anti-her2
ECSP088240A (es) Composición de trazodona para administración una vez por día
PE20121170A1 (es) Composicion de insulina de accion prolongada
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
PE20141384A1 (es) Composiciones de insulina de accion superrapida
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
MX2010009336A (es) Composiciones farmaceuticas acuosas que contienen complejos de borato-poliol.
AR069792A1 (es) Composicion agroquimica y metodo para preparar la misma
PE20080053A1 (es) Composiciones oftalmicas de alcaftadina
SI1933809T1 (sl) Sestavki za mazalno dajanje
CL2009000985A1 (es) Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo.
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
WO2007090192A3 (en) Stable one-part aqueous tooth whitening composition
CO6541634A2 (es) Composición de cereal hidrolizado
MA33384B1 (fr) Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
TW200744617A (en) Agent increasing the production of thioredoxin
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
BR112012018154A2 (pt) agonista alfa-2 adrenérgico tendo longa duração do efeito de redução da pressão intraocular
BR112015006464A2 (pt) composição farmacêutica compreendendo rebamipida
CO6592061A2 (es) Combinación triple para reducir la presión intraocular
ECSP10010683A (es) Una formulacion farmacéutica sólida